This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.
This content is restricted to subscribers
Continue Reading...
Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.
Members enjoy free PDF downloads on all articles. Join today
Author Affiliations
Department of Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Department of Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Clinical and Translational Pharmacy, College of Pharmacy; Departments of Psychiatry and Psychology; Michigan Institute for Clinical and Health Research (MICHR); and Education and Mentoring Group, University of Michigan, Ann Arbor, Michigan
Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, Minnesota
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, Minnesota eMenninger Department of Psychiatry and Behavioral Sciences and Department of Pediatrics, Baylor College of Medicine—Texas Children’s Hospital, Houston, Texas *Corresponding author: Chadi A. Calarge, MD, 1102 Bates Ave, Ste 790, Houston, TX 77030 ([email protected]).
Menninger Department of Psychiatry and Behavioral Sciences and Department of Pediatrics, Baylor College of Medicine—Texas Children’s Hospital, Houston, Texas
Scharko AM. Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review. J Am Acad Child Adolesc Psychiatry. 2004;43(9):1071–1079. PubMedCrossRef
Moreau C, Kågesten AE, Blum RW. Sexual dysfunction among youth: an overlooked sexual health concern. BMC Public Health. 2016;16(1):1170. PubMedCrossRef
O’Sullivan LF, Byers ES, Brotto LA, et al. A longitudinal study of problems in sexual functioning and related sexual distress among middle to late adolescents. J Adolesc Health. 2016;59(3):318–324. PubMedCrossRef
Anderson RM. Positive sexuality and its impact on overall well-being. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(2):208–214. PubMedCrossRef
Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol. 2009;29(2):157–164. PubMedCrossRef
Baldwin DS. Depression and sexual dysfunction. Br Med Bull. 2001;57(1):81–99. PubMedCrossRef
Kalmbach DA, Kingsberg SA, Ciesla JA. How changes in depression and anxiety symptoms correspond to variations in female sexual response in a nonclinical sample of young women: a daily diary study. J Sex Med. 2014;11(12):2915–2927. PubMedCrossRef
Deumic E, Butcher BD, Clayton AD, et al. Sexual functioning in adolescents with major depressive disorder. J Clin Psychiatry. 2016;77(7):957–962. PubMedCrossRef
Kronstein PD, Ishida E, Khin NA, et al. Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trials. J Clin Psychiatry. 2015;76(8):1050–1059. PubMedCrossRef
Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29(3):259–266. PubMedCrossRef
Anderson HD, Pace WD, Libby AM, et al. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clin Ther. 2012;34(1):113–123. PubMedCrossRef
Masand PS. Tolerability and adherence issues in antidepressant therapy. Clin Ther. 2003;25(8):2289–2304. PubMedCrossRef
Rothschild AJ. New directions in the treatment of antidepressant-induced sexual dysfunction. Clin Ther. 2000;22(suppl A):A42–A57, discussion A58–A61. PubMedCrossRef
O’Brien FE, Dinan TG, Griffin BT, et al. Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings. Br J Pharmacol. 2012;165(2):289–312. PubMedCrossRef
Uhr M, Tontsch A, Namendorf C, et al. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron. 2008;57(2):203–209. PubMedCrossRef
Fung KL, Pan J, Ohnuma S, et al. MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer. Cancer Res. 2014;74(2):598–608. PubMedCrossRef
Bly MJ, Bishop JR, Thomas KL, et al. P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects. J Sex Marital Ther. 2013;39(3):280–288. PubMedCrossRef
Bishop JR, Moline J, Ellingrod VL, et al. Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology. 2006;31(10):2281–2288. PubMedCrossRef
Giuliano F, Clément P. Physiology of ejaculation: emphasis on serotonergic control. Eur Urol. 2005;48(3):408–417. PubMedCrossRef
Williams VS, Edin HM, Hogue SL, et al. Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey. J Psychopharmacol. 2010;24(4):489–496. PubMedCrossRef
Rosenberg KP, Bleiberg KL, Koscis J, et al. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther. 2003;29(4):289–296. PubMedCrossRef
Calarge CA, Mills JA, Janz KF, et al. Body composition in adolescents during treatment with selective serotonin reuptake inhibitors. Pediatrics. 2017;140(1):e20163943. PubMedCrossRef
Calarge CA, Mills JA, Janz KF, et al. The effect of depression, generalized anxiety, and selective serotonin reuptake inhibitors on change in bone metabolism in adolescents and emerging adults. J Bone Miner Res. 2017;32(12):2367–2374. PubMedCrossRef
Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477–486. PubMedCrossRef
Beck AT. Depression: Clinical, Experimental, and Theoretical Aspects. New York, NY: Harper & Row; 1967.
American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540–548. PubMedCrossRef
Keller A, McGarvey EL, Clayton AH. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14). J Sex Marital Ther. 2006;32(1):43–52. PubMedCrossRef
Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. Vol. XXII. 1st ed. New York: Springer-Verlag New York; 2000.
Morrell CH, Brant LJ, Ferrucci L. Model choice can obscure results in longitudinal studies. J Gerontol A Biol Sci Med Sci. 2009;64(2):215–222. PubMedCrossRef
Little RJA, Rubin DB. Statistical Analysis With Missing Data. 2nd ed.
Skovlund CW, Mørch LS, Kessing LV, et al. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73(11):1154–1162. PubMedCrossRef
Lee JMLL. L. L.; Ang, S. B. Oral contraception and female sexual dysfunction in reproductive women. Sex Med Rev. 2017;5(1):31–44. CrossRef
Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000;97(7):3473–3478. PubMedCrossRef
Kulma I, Boonprasert K, Na-Bangchang K. Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: a systematic review. Cancer Chemother Pharmacol. 2019;84(5):959–975. PubMedCrossRef
Garcia JR, Reiber C. Hook-up behavior: a biopsychosocial perspective. J Soc Evol Cult Psychol. 2008;2(4):192–208. CrossRef
Althof SE, McMahon CG, Waldinger MD, et al. An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). Sex Med. 2014;2(2):60–90. PubMedCrossRef
Osis L, Bishop JR. Pharmacogenetics of SSRIs and sexual dysfunction. J Pharm (Cairo). 2010;3(12):3614–3628.
Farmer M, Yoon H, Goldstein I. Future targets for female sexual dysfunction. J Sex Med. 2016;13(8):1147–1165. PubMedCrossRef
McCabe MP, Connaughton C. Psychosocial factors associated with male sexual difficulties. J Sex Res. 2014;51(1):31–42. PubMedCrossRef
Barlow DH. Causes of sexual dysfunction: the role of anxiety and cognitive interference. J Consult Clin Psychol. 1986;54(2):140–148. PubMedCrossRef
Kempeneers PBV. Les apports de la pléthysmographie et de la psychologie cognitive dans la compréhension des relations entre l’anxiété et l’excitation sexuelle. J Ther Comport Cogn. 2008;18(4):161–165. CrossRef
Ott MA, Shew ML, Ofner S, et al. The influence of hormonal contraception on mood and sexual interest among adolescents. Arch Sex Behav. 2008;37(4):605–613. PubMedCrossRef
Smith NK, Jozkowski KN, Sanders SA. Hormonal contraception and female pain, orgasm and sexual pleasure. J Sex Med. 2014;11(2):462–470. PubMedCrossRef
Bancroft J, Sherwin BB, Alexander GM, et al. Oral contraceptives, androgens, and the sexuality of young women, II: the role of androgens. Arch Sex Behav. 1991;20(2):121–135. PubMedCrossRef
Wehry AM, Ramsey L, Dulemba SE, et al. Pharmacogenomic testing in child and adolescent psychiatry: an evidence-based Review. Curr Probl Pediatr Adolesc Health Care. 2018;48(2):40–49. PubMedCrossRef
Hockings JK, Pasternak AL, Erwin AL, et al. Pharmacogenomics: an evolving clinical tool for precision medicine. Cleve Clin J Med. 2020;87(2):91–99. PubMedCrossRef
Zhu J, Klein-Fedyshin M, Stevenson JM. Serotonin transporter gene polymorphisms and selective serotonin reuptake inhibitor tolerability: review of pharmacogenetic evidence. Pharmacotherapy. 2017;37(9):1089–1104. PubMedCrossRef
Stevenson JM, Bishop JR. Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunction. Pharmacogenomics. 2014;15(14):1791–1806. PubMedCrossRef
Kato M, Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry. 2010;15(5):473–500. PubMedCrossRef
Lewis MA, Atkins DC, Blayney JA, et al. What is hooking up? examining definitions of hooking up in relation to behavior and normative perceptions. J Sex Res. 2013;50(8):757–766. PubMedCrossRef
Freidl EK, Stroeh OM, Elkins RM, et al. Assessment and treatment of anxiety among children and adolescents. Focus Am Psychiatr Publ. 2017;15(2):144–156. PubMedCrossRef
Cavazos-Rehg PA, Krauss MJ, Spitznagel EL, et al. Age of sexual debut among US adolescents. Contraception. 2009;80(2):158–162. PubMedCrossRef
Upchurch DM, Levy-Storms L, Sucoff CA, et al. Gender and ethnic differences in the timing of first sexual intercourse. Fam Plann Perspect. 1998;30(3):121–127. PubMedCrossRef
Hicks JK, Bishop JR, Sangkuhl K, et al; Clinical Pharmacogenetics Implementation Consortium. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015;98(2):127–134. PubMedCrossRef
Levine A, McGlinchey E. Assessing sexual symptoms and side effects in adolescents. Pediatrics. 2015;135(4):e815–e817. PubMedCrossRef